Metagenomi Therapeutics Inc Revenue per Employee (MGX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Metagenomi Therapeutics Inc   (NASDAQ: MGX)
 

Metagenomi Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Metagenomi Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 113,958, below the company average number of $268,116.
Within the Healthcare sector Employees of 399 other companies have achieved higher revenue per employee. While Metagenomi Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 2726 to 3011. Metagenomi Therapeutics Inc has 119 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MGX Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change - -69.76 % -59.32 % -24.8 % -57.45 %
Sales per Employee (TTM) $ 113,958 187,655 211,849 259,773 283,765
MGX's Total Ranking # 3011 # 2726 # 2262 # 1153 # 1146
Seq. Revenue Change - -68.09 % -54.83 % 1.72 % 106.28 %

MGX Company Profile >> Back to MGX Efficiency Comparisons >> Compare MGX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 49
Healthcare Sector # 400
Overall Market # 3011

Revenue per Employee Statistics
High Average Low
$ 439,454 $ 268,116 $ 113,958
(Dec 31 2024)   (Jun 30 2026)



Financial Statements
Metagenomi Therapeutics Inc 's Revenue MRQ $ 0 Millions Visit MGX's Income Statement
Metagenomi Therapeutics Inc 's Revenues TTM $ 14 Millions Visit MGX's aggregate revenue growth
What are MGX's Sales? Visit MGX's Sales by Segment




Other Ratios
Metagenomi Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MGX's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MGX's Competitors
Revenue per Employee for MGX's Suppliers
Revenue per Employee for MGX's Customers

You may also want to know
MGX's Sales Growth Rates MGX's Pe Price to earnings ratio MGX's Receivables Turnover Ratio MGX's Stock Quote
MGX's Net Income Growth Rates MGX's Ps Price to Sales ratio MGX's Sales per Employee MGX's Asset Turnover Ratio
MGX's Net Margin MGX's Pb Price to Book ratio MGX's Financial Strength Ratios MGX's Dividend Payout Ratio
Date modified: 2026-08-13T09:09:46+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Hcw Biologics Inc   195,508.54 $ 6.843  Million 35 
Utah Medical Products Inc  194,967.21 $ 35.679  Million 183 
Arcus Biosciences Inc   194,675.54 $ 117.000  Million 601 
Gyre Therapeutics Inc   193,176.38 $ 119.383  Million 618 
Tao Synergies Inc   193,124.75 $ 0.772  Million 4 
Safe Pro Group Inc   192,088.60 $ 2.881  Million 15 
Monte Rosa Therapeutics Inc   191,513.33 $ 28.727  Million 150 
Fortrea Holdings Inc   187,167.83 $ 2,676.500  Million 14,300 
Agios Pharmaceuticals Inc   182,107.41 $ 98.338  Million 540 
Grail Inc   181,607.69 $ 165.263  Million 910 
Davita Inc   179,610.85 $ 14,009.646  Million 78,000 
Universal Health Services Inc   178,467.85 $ 18,114.487  Million 101,500 
Concentra Group Holdings Parent Inc   175,958.85 $ 2,287.465  Million 13,000 
Lineage Cell Therapeutics Inc   169,909.09 $ 13.083  Million 77 
Integer Holdings Corporation  167,511.00 $ 1,842.621  Million 11,000 
Bioage Labs Inc   167,016.13 $ 10.355  Million 62 
Retractable Technologies Inc  166,605.48 $ 33.488  Million 201 
Icu Medical Inc  166,153.69 $ 2,159.998  Million 13,000 
Prophase Labs Inc   165,789.47 $ 3.150  Million 19 
Bionexus Gene Lab Corp   164,556.89 $ 3.127  Million 19 
Chemed Corporation  164,126.30 $ 2,595.001  Million 15,811 
Humacyte Inc   163,445.65 $ 30.074  Million 184 
Stoke Therapeutics Inc   162,282.35 $ 27.588  Million 170 
Ocular Therapeutix Inc   160,166.15 $ 52.054  Million 325 
Seer Inc   159,744.44 $ 14.377  Million 90 
Intellia Therapeutics Inc   157,840.85 $ 59.506  Million 377 
Autolus Therapeutics Plc  155,689.66 $ 117.390  Million 754 
Hyperion Defi inc   155,633.22 $ 1.401  Million 9 
Marpai Inc  155,467.29 $ 16.635  Million 107 
National Vision Holdings Inc   154,774.39 $ 2,033.426  Million 13,138 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.